Basal ganglia and parkinson's disease: neurobiological and pharmacological aspects in animals and man
- 1 January 1984
- journal article
- research article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 86 (3) , 178-195
- https://doi.org/10.1016/0303-8467(84)90195-1
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Estrogen inhibits the dopaminergic supersensitivity induced by neurolepticsLife Sciences, 1982
- Characterization of normal and supersensitive dopamine receptors: Effects of ergot drugs and neuropeptidesJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1981
- Multiple receptors for brain dopamine in behavior regulation: Concept of dopamine-e and dopamine-i receptorsLife Sciences, 1980
- Post-mortem distribution of dopamine and homo-vanillic acid in human brain, variations related to age, and a review of the literatureJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1979
- Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndromeJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1977
- Decrease in neostriatal blood flow after d-amphetamine administration or electrical stimulation of the substantia nigraBrain Research, 1977
- (3,4-Dihydroxy-phenylamino)-2-imidazoline (DPI), a new potent agonist at dopamine receptors mediating neuronal inhibitionJournal of Pharmacy and Pharmacology, 1975
- Structure activity relationship for central and peripheral alpha adrenergic activities of imidazoline derivativesLife Sciences, 1975
- L-Dopa in Parkinsonism and the Influence of Previous ThalamotomyBMJ, 1971
- Simple and complex finger movement performance of patients with Parkinsonism before and after a unilateral stereotaxic thalamotomy.Journal of Neurology, Neurosurgery & Psychiatry, 1970